FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2942122608> ?p ?o ?g. }

• W2942122608 endingPage "978" @default.
• W2942122608 startingPage "971" @default.
• W2942122608 abstract "Background: The objective of this study was to evaluate the overall survival (OS) of radioiodine (131I) treatments alone or combined with non-131I treatments in patients with bone metastases (BM) of differentiated thyroid cancer (DTC). Methods: This was a retrospective study of patients who were evaluated between 2001 and 2018 at MedStar Washington Hospital Center and who had DTC, BM, and at least one 131I treatment after the diagnosis of BM. The OS was analyzed by Kaplan-Meier survival curves and was compared by log-rank test between two groups: patients who received 131I treatments alone and those who received treatments combining 131I with non-131I treatments (CombTx). Non-131I treatments include surgery, radiofrequency ablation, cryotherapy, arterial embolization, external beam radiation, Cyberknife, systemic targeted therapy, and anti-resorptive medication. Results: A total of 77 patients met the above criteria and were followed up to 41 years. Thirty percent (23/77) of patients received 131I treatment alone, and 70% (54/77) received CombTx. For 131I treatment alone, the median survival was 3.9 years, and the 1-, 2-, 3-, 5-, and 10-year OS rates were 86%, 81%, 61%, 35%, and 23%, respectively. For CombTx, the median survival was 7.7 years, and the 1-, 2-, 3-, 5-, and 10-year OS rates were 96%, 92%, 86%, 69%, and 30%, respectively. Patients who had undergone initial 131I therapy within six months post thyroidectomy demonstrated a better median survival after BM diagnosis than those whose initial 131I therapy was six months or more after thyroidectomy (6.5 vs. 0.5 years; p < 0.001). Patients who received external beam radiation therapy demonstrated a better median survival than those who did not (7.8 vs. 4.4 years; p = 0.016). Patients who received denosumab demonstrated a better median survival than those who did not (7.7 vs. 5.2 years; p = 0.03). Patients who were <55 years of age at the initial diagnosis of DTC or at the initial diagnosis of BM had a better median OS than those diagnosed at ≥55 years of age (both p = 0.01). In the multivariate analysis, only age at initial diagnosis of DTC and initial 131I therapy within six months post thyroidectomy, and multiple 131I treatments were independent prognostic factors. Conclusions: In patients with DTC with BM, 131I treatment in combination with one or more non-131I direct and systemic treatments was associated with a significant increase in OS compared with those patients who were treated by 131I treatment alone." @default.
• W2942122608 created "2019-05-03" @default.
• W2942122608 creator A5004080743 @default.
• W2942122608 creator A5007079943 @default.
• W2942122608 creator A5013056369 @default.
• W2942122608 creator A5018577872 @default.
• W2942122608 creator A5025240640 @default.
• W2942122608 creator A5039546377 @default.
• W2942122608 creator A5068782465 @default.
• W2942122608 creator A5088428113 @default.
• W2942122608 date "2019-07-01" @default.
• W2942122608 modified "2023-09-30" @default.
• W2942122608 title "Improved Survival After Multimodal Approach with ¹³¹I Treatment in Patients with Bone Metastases Secondary to Differentiated Thyroid Cancer" @default.
• W2942122608 cites W1567842098 @default.
• W2942122608 cites W1834282953 @default.
• W2942122608 cites W1966006514 @default.
• W2942122608 cites W1986531739 @default.
• W2942122608 cites W1986985742 @default.
• W2942122608 cites W2022724243 @default.
• W2942122608 cites W2027611938 @default.
• W2942122608 cites W2027713082 @default.
• W2942122608 cites W2028278716 @default.
• W2942122608 cites W2040642592 @default.
• W2942122608 cites W2045367553 @default.
• W2942122608 cites W2059336644 @default.
• W2942122608 cites W2087440541 @default.
• W2942122608 cites W2094776758 @default.
• W2942122608 cites W2112315183 @default.
• W2942122608 cites W2114374078 @default.
• W2942122608 cites W2115643427 @default.
• W2942122608 cites W2145150141 @default.
• W2942122608 cites W2152489250 @default.
• W2942122608 cites W2168378503 @default.
• W2942122608 cites W2233231343 @default.
• W2942122608 cites W2320378887 @default.
• W2942122608 cites W2411516949 @default.
• W2942122608 cites W2413093466 @default.
• W2942122608 cites W2496636312 @default.
• W2942122608 cites W2523331602 @default.
• W2942122608 cites W2529588254 @default.
• W2942122608 cites W2725871203 @default.
• W2942122608 cites W2765084664 @default.
• W2942122608 cites W4236654073 @default.
• W2942122608 cites W2050010052 @default.
• W2942122608 doi "https://doi.org/10.1089/thy.2018.0582" @default.
• W2942122608 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31017051" @default.
• W2942122608 hasPublicationYear "2019" @default.
• W2942122608 type Work @default.
• W2942122608 sameAs 2942122608 @default.
• W2942122608 citedByCount "24" @default.
• W2942122608 countsByYear W29421226082020 @default.
• W2942122608 countsByYear W29421226082021 @default.
• W2942122608 countsByYear W29421226082022 @default.
• W2942122608 countsByYear W29421226082023 @default.
• W2942122608 crossrefType "journal-article" @default.
• W2942122608 hasAuthorship W2942122608A5004080743 @default.
• W2942122608 hasAuthorship W2942122608A5007079943 @default.
• W2942122608 hasAuthorship W2942122608A5013056369 @default.
• W2942122608 hasAuthorship W2942122608A5018577872 @default.
• W2942122608 hasAuthorship W2942122608A5025240640 @default.
• W2942122608 hasAuthorship W2942122608A5039546377 @default.
• W2942122608 hasAuthorship W2942122608A5068782465 @default.
• W2942122608 hasAuthorship W2942122608A5088428113 @default.
• W2942122608 hasConcept C126322002 @default.
• W2942122608 hasConcept C141071460 @default.
• W2942122608 hasConcept C167135981 @default.
• W2942122608 hasConcept C2776283816 @default.
• W2942122608 hasConcept C2776651944 @default.
• W2942122608 hasConcept C2777074255 @default.
• W2942122608 hasConcept C2779761222 @default.
• W2942122608 hasConcept C2780387249 @default.
• W2942122608 hasConcept C3018694869 @default.
• W2942122608 hasConcept C509974204 @default.
• W2942122608 hasConcept C526584372 @default.
• W2942122608 hasConcept C71924100 @default.
• W2942122608 hasConceptScore W2942122608C126322002 @default.
• W2942122608 hasConceptScore W2942122608C141071460 @default.
• W2942122608 hasConceptScore W2942122608C167135981 @default.
• W2942122608 hasConceptScore W2942122608C2776283816 @default.
• W2942122608 hasConceptScore W2942122608C2776651944 @default.
• W2942122608 hasConceptScore W2942122608C2777074255 @default.
• W2942122608 hasConceptScore W2942122608C2779761222 @default.
• W2942122608 hasConceptScore W2942122608C2780387249 @default.
• W2942122608 hasConceptScore W2942122608C3018694869 @default.
• W2942122608 hasConceptScore W2942122608C509974204 @default.
• W2942122608 hasConceptScore W2942122608C526584372 @default.
• W2942122608 hasConceptScore W2942122608C71924100 @default.
• W2942122608 hasIssue "7" @default.
• W2942122608 hasLocation W29421226081 @default.
• W2942122608 hasLocation W29421226082 @default.
• W2942122608 hasOpenAccess W2942122608 @default.
• W2942122608 hasPrimaryLocation W29421226081 @default.
• W2942122608 hasRelatedWork W1971665703 @default.
• W2942122608 hasRelatedWork W1994448744 @default.
• W2942122608 hasRelatedWork W2153808903 @default.
• W2942122608 hasRelatedWork W2360503543 @default.
• W2942122608 hasRelatedWork W2364998975 @default.
• W2942122608 hasRelatedWork W2405097422 @default.

• next